Mechanism of Action of TRAVATAN 0.004% in Subjects With Glaucoma or Ocular Hypertension

Phase 4

Completed

• Conditions: Glaucoma; Ocular Hypertension

• Registration Number: NCT00061503
• Lead Sponsor: Alcon Research

Brief Summary

The primary objective of this study is to describe the effect of TRAVATAN 0.004% Ophthalmic Solution on aqueous humor dynamics in subjects with a clinical diagnosis of open angle glaucoma (OAG) or ocular hypertension (OHT).

Detailed Description

Not available

Study Timeline

• Study Start: 2003-04
• Study First Submitted: 2003-05-28
• Study First Submitted QC: 2003-05-29
• Study First Posted: 2003-05-30
• Primary Completion: 2004-03
• Study Completion: 2004-03
• Status Verified: 2008-08
• Last Update Submitted: 2008-08-04
• Last Update Posted: 2008-08-05

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Trial Locations

Locations (1)

Alcon Call Center; 🇺🇸 Call for Details, Nebraska, United States